"MFN" の関連情報検索結果

MFN Drug Pricing Proposal Raises Questions Around Access, Innovation, and Commercial Coverage - AJMC



MFN Drug Pricing Proposal Raises Questions Around Access, Innovation, and Commercial Coverage  AJMC

CMS signals new collaboration era for pharma - BioXconomy



CMS signals new collaboration era for pharma  BioXconomy

Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma - Fierc...



Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma  Fierce Pharma

Initial data hint that US MFN pricing is hitting access in Europe - BioWorld News



Initial data hint that US MFN pricing is hitting access in Europe  BioWorld News

President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing - KFF



President Trump Proposes Codifying MFN Drug Pricing Deals But Key Details Are Missing  KFF

Eli Lilly Intends to Pursue Global Drug Launches Despite MFN Policy - NAVLIN DAILY



Eli Lilly Intends to Pursue Global Drug Launches Despite MFN Policy  NAVLIN DAILY

Is this farewell to MFN, the non-discrimination principle of the world trading system? - Peterson...



Is this farewell to MFN, the non-discrimination principle of the world trading system?  Peterson Institute for International Economics

CMS puts patients and innovation at risk with MFN - PhRMA



CMS puts patients and innovation at risk with MFN  PhRMA

Lilly to Launch Drugs Globally Despite Pricing Pressure - Bloomberg



Lilly to Launch Drugs Globally Despite Pricing Pressure  Bloomberg

Fertilizers Europe releases statement on MFN tariff suspension - World Fertilizer



Fertilizers Europe releases statement on MFN tariff suspension  World Fertilizer

Most Favored Nation Drug Pricing and Manufacturer Agreements - Jones Day



Most Favored Nation Drug Pricing and Manufacturer Agreements  Jones Day

How IRA, MFN, and 340B Are Reshaping Drug Pricing - Drug Topics



How IRA, MFN, and 340B Are Reshaping Drug Pricing  Drug Topics

Trump Administration Pursues MFN Pricing for Prescription Drugs - Crowell & Moring LLP



Trump Administration Pursues MFN Pricing for Prescription Drugs  Crowell & Moring LLP

CPI | Trump’s MFN Initiative: The EU Competition Law Perspective - PYMNTS.com



CPI | Trump’s MFN Initiative: The EU Competition Law Perspective  PYMNTS.com

Prying open Pandora's box by scrapping MFN - Peterson Institute for International Economics



Prying open Pandora's box by scrapping MFN  Peterson Institute for International Economics

MFN drug pricing risks reviving a harmful metric the U.S. rejected - PhRMA



MFN drug pricing risks reviving a harmful metric the U.S. rejected  PhRMA

AstraZeneca CEO's conservative MFN model excludes reference markets from forecast - Fierce Pharma



AstraZeneca CEO's conservative MFN model excludes reference markets from forecast  Fierce Pharma

PhRMA’s comments on CMS’ MFN Medicare Proposals: GLOBE and GUARD - PhRMA



PhRMA’s comments on CMS’ MFN Medicare Proposals: GLOBE and GUARD  PhRMA

MFN undermines U.S. biopharmaceutical innovation - PhRMA



MFN undermines U.S. biopharmaceutical innovation  PhRMA

CMS’ MFN proposals won’t help seniors despite lofty promises - PhRMA



CMS’ MFN proposals won’t help seniors despite lofty promises  PhRMA

CMS Issues Proposed Rules to Impose International MFN Drug Pricing for Portion of Medicare Part B...



CMS Issues Proposed Rules to Impose International MFN Drug Pricing for Portion of Medicare Part B and D Utilization Under “GLOBE” and “GUARD” Models  Reed Smith LLP

Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026 - BioSpace



Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026  BioSpace

U.S. Pharma Tariffs And MFN Become Law After April 2 Update - Clinical Leader



U.S. Pharma Tariffs And MFN Become Law After April 2 Update  Clinical Leader

Trump’s MFN Pricing Expected To Delay More European Drug Launches - BioSpace



Trump’s MFN Pricing Expected To Delay More European Drug Launches  BioSpace

Why MFN Pricing Hurts Patients and Innovation - U.S. Chamber of Commerce



Why MFN Pricing Hurts Patients and Innovation  U.S. Chamber of Commerce

White House looks to expand MFN pricing for $530B-plus in savings - BioWorld News



White House looks to expand MFN pricing for $530B-plus in savings  BioWorld News

Can Trump win over critics with MFN drug pricing plan? Former Biden advisor weighs in - Fierce Ph...



Can Trump win over critics with MFN drug pricing plan? Former Biden advisor weighs in  Fierce Pharma

CMS Proposes MFN Drug Pricing Strategy for Mandatory GLOBE and GUARD Models - Jones Day



CMS Proposes MFN Drug Pricing Strategy for Mandatory GLOBE and GUARD Models  Jones Day

CMS Announces Voluntary Medicaid MFN Pricing Model - NAVLIN DAILY



CMS Announces Voluntary Medicaid MFN Pricing Model  NAVLIN DAILY

WTO Matters: Whither MFN – Its Relevance in a Rapidly Changing World - wita.org



WTO Matters: Whither MFN – Its Relevance in a Rapidly Changing World  wita.org

Editorial: Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling - BioSpace



Editorial: Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling  BioSpace

Most Favored Nation and Prescription Drug Pricing: Foresight Is 20/20 - Paragon Health Institute



Most Favored Nation and Prescription Drug Pricing: Foresight Is 20/20  Paragon Health Institute

50+ Free Market Groups, Advocates Oppose Codification of Most-Favored-Nation Drug Pricing - Ameri...



50+ Free Market Groups, Advocates Oppose Codification of Most-Favored-Nation Drug Pricing  Americans for Tax Reform

Advocacy group files FOIA lawsuit to gain further clarity on Trump administration's MFN pricing d...



Advocacy group files FOIA lawsuit to gain further clarity on Trump administration's MFN pricing deals  Fierce Pharma

What Potential Fallout Will MFN Policies Have? - PharmExec.com



What Potential Fallout Will MFN Policies Have?  PharmExec.com

U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026 - Sidley Austin



U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026  Sidley Austin

Say "NO" to Importing Foreign, Socialist Drug Price Controls - Americans for Tax Reform



Say "NO" to Importing Foreign, Socialist Drug Price Controls  Americans for Tax Reform

AbbVie inks MFN drug pricing deal, pledges $100bn to US R&D - Pharmaceutical Technology



AbbVie inks MFN drug pricing deal, pledges $100bn to US R&D  Pharmaceutical Technology

The Long-Term Outlook for MFN Pricing: Far-Reaching Issues and Considerations - PharmExec.com



The Long-Term Outlook for MFN Pricing: Far-Reaching Issues and Considerations  PharmExec.com

Policymakers shouldn’t double down on the IRA’s flaws with MFN - PhRMA



Policymakers shouldn’t double down on the IRA’s flaws with MFN  PhRMA

Democrats press 11 pharmas for 'any evidence' their Trump pricing deals deliver savings for Medic...



Democrats press 11 pharmas for 'any evidence' their Trump pricing deals deliver savings for Medicaid  Fierce Pharma

To gain tariff exemptions, drugmakers must reveal US production plans - Fierce Pharma



To gain tariff exemptions, drugmakers must reveal US production plans  Fierce Pharma

CMS undermines medical progress with MFN price controls - PhRMA



CMS undermines medical progress with MFN price controls  PhRMA

Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing - AJMC



Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing  AJMC

Walking a tightrope: Navigating US most-favored-nation prescription drug pricing in Canada - Nort...



Walking a tightrope: Navigating US most-favored-nation prescription drug pricing in Canada  Norton Rose Fulbright

Worried Trump's MFN push will 'destroy biotech innovation,' midsize companies form coalition to f...



Worried Trump's MFN push will 'destroy biotech innovation,' midsize companies form coalition to fight back  Fierce Biotech

Trump most-favored nation drug pricing deals end after three years for some companies - statnews.com



Trump most-favored nation drug pricing deals end after three years for some companies  statnews.com

J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts - Pharmaceutical T...



J&J cuts MFN deal with the Trump administration, bolsters US onshoring efforts  Pharmaceutical Technology

Drug pricing deal to generate savings of $64.3 billion over 10 years, White House says - Reuters



Drug pricing deal to generate savings of $64.3 billion over 10 years, White House says  Reuters

Trump eyes 100% tariff rate for companies that have not struck MFN deals: Bloomberg - Fierce Pharma



Trump eyes 100% tariff rate for companies that have not struck MFN deals: Bloomberg  Fierce Pharma

Most Favored Nation Drug Pricing: Analysis and Implications - Pharmacy Times



Most Favored Nation Drug Pricing: Analysis and Implications  Pharmacy Times

MFN and TrumpRx: What’s the real impact for the American consumer? - pharmaphorum



MFN and TrumpRx: What’s the real impact for the American consumer?  pharmaphorum

Sonam Zomba defends MFN title, CM Khandu praises her performance - The News Mill



Sonam Zomba defends MFN title, CM Khandu praises her performance  The News Mill

From MFN to IRA, Experts Warn of a System Under Pressure in Wide-Ranging Policy Webinar - AJMC



From MFN to IRA, Experts Warn of a System Under Pressure in Wide-Ranging Policy Webinar  AJMC

The Longer-Term Impact of MFN Pricing - Pharmaceutical Commerce



The Longer-Term Impact of MFN Pricing  Pharmaceutical Commerce

U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact - Clinical Leader



U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact  Clinical Leader

MFN and IRA’s Impact of Innovation and Global Strategy: Q&A with Dr. Stella Vnook - PharmExec.com



MFN and IRA’s Impact of Innovation and Global Strategy: Q&A with Dr. Stella Vnook  PharmExec.com

Drug companies sign "Most Favored Nation" deals, then raise prices anyway - drugdiscoverytrends.com



Drug companies sign "Most Favored Nation" deals, then raise prices anyway  drugdiscoverytrends.com

The Trump Administration Continues to Make Drug Pricing Moves, Announces First MFN Agreement - Akin



The Trump Administration Continues to Make Drug Pricing Moves, Announces First MFN Agreement  Akin

Questions on how new IRA drug prices will affect MFN agreements - Pharmaceutical Technology



Questions on how new IRA drug prices will affect MFN agreements  Pharmaceutical Technology

Federal actions signal MFN drug pricing goal remains a priority - McDermott Will & Schulte



Federal actions signal MFN drug pricing goal remains a priority  McDermott Will & Schulte

MFN – Not dead yet! - wita.org



MFN – Not dead yet!  wita.org

Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices - Pharma...



Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices  Pharmacy Times

Biopharma bites: PhRMA rebukes Trump's call to codify MFN, plus Pfizer's base editing deal and mo...



Biopharma bites: PhRMA rebukes Trump's call to codify MFN, plus Pfizer's base editing deal and more from Charles River  FirstWord Pharma

Issue of Equity - TradingView



Issue of Equity  TradingView

US pharma MFN and tariff dynamics: What EU and UK leaders need to know - pharmaphorum



US pharma MFN and tariff dynamics: What EU and UK leaders need to know  pharmaphorum

Lilly, Novo to discount weight-loss drugs in MFN pricing deal with Trump - FirstWord Pharma



Lilly, Novo to discount weight-loss drugs in MFN pricing deal with Trump  FirstWord Pharma

Side Letters and MFN Mechanics — Designing Enforceab... - Dechert



Side Letters and MFN Mechanics — Designing Enforceab...  Dechert

The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S. - PharmExec.com



The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.  PharmExec.com

9 pharma giants reach US drug price deals with Trump administration - Fierce Pharma



9 pharma giants reach US drug price deals with Trump administration  Fierce Pharma

J&J becomes latest pharma heavyweight to embrace MFN pricing - FirstWord Pharma



J&J becomes latest pharma heavyweight to embrace MFN pricing  FirstWord Pharma

Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says - CNBC



Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says  CNBC

The Great Healthcare Plan, MFN drug prices and the political implications of the end of ACA enhan...



The Great Healthcare Plan, MFN drug prices and the political implications of the end of ACA enhanced subsidies: Here are 7 takeaways from the MHE-AJMC webinar  Managed Healthcare Executive

US comes up with two mandatory IRP use pricing models under Trump’s MFN strategy - Pharmaceutical...



US comes up with two mandatory IRP use pricing models under Trump’s MFN strategy  Pharmaceutical Technology

Beyond Forecasts: Navigating MFN Uncertainty - Fierce Pharma



Beyond Forecasts: Navigating MFN Uncertainty  Fierce Pharma

Pharmaceutical Policy in Motion: Updates on the Trump Administration’s Drug Pricing Initiatives -...



Pharmaceutical Policy in Motion: Updates on the Trump Administration’s Drug Pricing Initiatives  Mintz

The Ongoing Impact of MFN Pricing - PharmExec.com



The Ongoing Impact of MFN Pricing  PharmExec.com

Decoding CMS drug pricing models, benchmarks and MFN alignment - EY



Decoding CMS drug pricing models, benchmarks and MFN alignment  EY

ISPOR 2026: Investors Turn Away from MFN to Focus on China - NAVLIN DAILY



ISPOR 2026: Investors Turn Away from MFN to Focus on China  NAVLIN DAILY

ViewPoints: A policy insider explains the risks MFN pricing poses to biotech - FirstWord Pharma



ViewPoints: A policy insider explains the risks MFN pricing poses to biotech  FirstWord Pharma

US starts engaging drugmakers on putting Trump's MFN pricing into law - Reuters



US starts engaging drugmakers on putting Trump's MFN pricing into law  Reuters

J&J strikes MFN deal with Trump, reveals plan to build 2 US manufacturing sites - Fierce Pharma



J&J strikes MFN deal with Trump, reveals plan to build 2 US manufacturing sites  Fierce Pharma

MFN, Stopping Additional Insurer Subsidies, More Medicaid Fraud, and RSC Proposals - Paragon Heal...



MFN, Stopping Additional Insurer Subsidies, More Medicaid Fraud, and RSC Proposals  Paragon Health Institute

Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals - PharmExec.com



Senate Democrats Expand Efforts to Expose Details of MFN Pharma Deals  PharmExec.com

AstraZeneca agrees to MFN pricing, joins TrumpRx - FirstWord Pharma



AstraZeneca agrees to MFN pricing, joins TrumpRx  FirstWord Pharma

How Will MFN’s Effects on Medicare Impact Innovation? - PharmExec.com



How Will MFN’s Effects on Medicare Impact Innovation?  PharmExec.com

How Does MFN Pricing Work Within TrumpRx? - PharmExec.com



How Does MFN Pricing Work Within TrumpRx?  PharmExec.com

CMS extends deadline for MFN pricing pilot scheme - pharmaphorum



CMS extends deadline for MFN pricing pilot scheme  pharmaphorum

Pharma R&D set to endure despite rising MFN costs - Clinical Trials Arena



Pharma R&D set to endure despite rising MFN costs  Clinical Trials Arena

AstraZeneca CEO visits White House to formalize MFN agreement with Trump - Fierce Pharma



AstraZeneca CEO visits White House to formalize MFN agreement with Trump  Fierce Pharma

In brief SOTU remarks, Trump asks Congress to "codify" MFN - pharmaphorum



In brief SOTU remarks, Trump asks Congress to "codify" MFN  pharmaphorum

Trump administration announces MFN drug pricing deal with Pfizer - Pharmaceutical Technology



Trump administration announces MFN drug pricing deal with Pfizer  Pharmaceutical Technology

Pfizer shakes hands with White House on drug discounts under MFN programme - Pharmaceutical Techn...



Pfizer shakes hands with White House on drug discounts under MFN programme  Pharmaceutical Technology

Is Waiting the Riskiest Drug Pricing Strategy? Why Scenario Planning Is the Smart First Move on M...



Is Waiting the Riskiest Drug Pricing Strategy? Why Scenario Planning Is the Smart First Move on MFN  Syneos Health

WTO Matters: Whither MFN – Its Relevance in a Rapidly Changing World - wita.org



WTO Matters: Whither MFN – Its Relevance in a Rapidly Changing World  wita.org

Pharmalittle: We're reading about Trump's MFN deals, 340B program controversies, and much more - ...



Pharmalittle: We're reading about Trump's MFN deals, 340B program controversies, and much more  statnews.com

Novo, Lilly sign MFN pricing deal with Trump administration - pharmaphorum



Novo, Lilly sign MFN pricing deal with Trump administration  pharmaphorum

Transforming US drug access and production: MFN pricing deals and historic manufacturing investme...



Transforming US drug access and production: MFN pricing deals and historic manufacturing investments  Pharmaceutical Technology

Pfizer inks first MFN drug pricing deal as US introduces 'TrumpRx' DTC site - FirstWord Pharma



Pfizer inks first MFN drug pricing deal as US introduces 'TrumpRx' DTC site  FirstWord Pharma

Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech - BioSpace



Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech  BioSpace